Image For Activity Cover
Integrating Hepatitis C Care into your MAT Clinic
American Psychiatric Association
Yavar Moghimi, M.D., AmeriHealth Caritas
Target Audience
Physicians, psychologists, social workers, and healthcare teams.
Webinar Description
The “Integrating Hepatitis C Care into your MAT Clinic” webinar, presented by faculty expert, Dr. Yavar Moghimi will provide an overview of the evidence of medication-assisted treatments (MAT), such as buprenorphine or methadone, as an effective preventative method against blood-borne viruses commonly associated with injection opioid use such as hepatitis C virus (HCV).This activity will highlight the impact of applying the HCV care continuum on the treatment outcomes for OUD patients with comorbid infections. Best practices on how to effectively interact and talk with psychiatric patients about their substance use and how MAT can act as an effective co-prevention method for HCV infection.
Educational Objectives

At the conclusion of this activity, learners should be able to:

  • Describe the HCV care continuum and its application within MAT.
  • Apply MAT in coordination with HCV care of patients.
  • Cite and utilize evidence-based interventions to enhance the HCV care continuum.
Availability: Retired
Cost: FREE
Credit Offered:
No Credit Offered
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.

Funding for this initiative was made possible (in part) by grant nos. 1H79TI086770 and 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

For Buprenorphine Training Inquiries, email PCSS-MOUD.


Powered By